Skip to main content

Early Changes of Gut GVHD: Differential Diagnosis and Criteria for Crypt Cell Apoptosis

  • Chapter
  • First Online:
Pathology of Graft vs. Host Disease

Abstract

The early changes of GVHD overlap with those caused by mucosal damage from conditioning chemoradiation therapy. This overlap occurs in the first several weeks post-transplant. The widespread distribution of the mucosal damage including marked edema, hemorrhage, architectural disarray, and crypt atypia suggests chemoirradiation damage. In contrast, the earliest change of GVHD is individual crypt cell apoptosis. The overlap of conditioning toxicity with GVHD is much less likely in patients who receive nonmyeloablative or reduced intensity conditioning. The precise definitions for apoptotic enterocytes, crypt destruction, and crypt abscesses have now been standardized, allowing reliable inter-institutional comparisons. These are important to allow comparison of results from different institutions. A number of other entities cause apoptotic changes resembling GVHD, including infections and some drugs such as NSAIDs, proton pump inhibitors, and mycophenolate mofetil.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sale GE, Shulman HM, McDonald GB, Thomas ED. Gastrointestinal graft-versus-host disease in man. A clinicopathologic study of the rectal biopsy. Am J Surg Pathol. 1979;3(4):291–9.

    Article  CAS  PubMed  Google Scholar 

  2. Epstein RJ, McDonald GB, Sale GE, Shulman HM, Thomas ED. The diagnostic accuracy of the rectal biopsy in acute graft-versus-host disease: a prospective study of thirteen patients. Gastroenterology. 1980;78(4):764–71.

    CAS  PubMed  Google Scholar 

  3. Shulman HM, Cardona DM, Greenson JK, et al. NIH consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 pathology working group report. Biol Blood Marrow Transplant. 2015;21(4):589–603.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Kreft A, Mottok A, Mesteri I, et al. Consensus diagnostic histopathological criteria for acute gastrointestinal graft versus host disease improve interobserver reproducibility. Virchows Arch. 2015;467(3):255–63.

    Article  PubMed  Google Scholar 

  5. Hall PA, Coates PJ, Ansari B, Hopwood D. Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis. J Cell Sci. 1994;107(Pt 12):3569–77.

    CAS  PubMed  Google Scholar 

  6. Saisho Y, Manesso E, Gurlo T, et al. Development of factors to convert frequency to rate for beta-cell replication and apoptosis quantified by time-lapse video microscopy and immunohistochemistry. Am J Physiol Endocrinol Metab. 2009;296(1):E89–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Sale GE, Lerner KG, Barker EA, Shulman HM, Thomas ED. The skin biopsy in the diagnosis of acute graft-versus-host disease in man. Am J Pathol. 1977;89(3):621–36.

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Slavin RE, Dias MA, Saral R. Cytosine arabinoside induced gastrointestinal toxic alterations in sequential chemotherapeutic protocols: a clinical-pathologic study of 33 patients. Cancer. 1978;42(4):1747–59.

    Article  CAS  PubMed  Google Scholar 

  9. Parfitt JR, Driman DK. Pathological effects of drugs on the gastrointestinal tract: a review. Hum Pathol. 2007;38(4):527–36.

    Article  CAS  PubMed  Google Scholar 

  10. Papadimitriou JC, Cangro CB, Lustberg A, et al. Histologic features of mycophenolate mofetil-related colitis: a graft-versus-host disease-like pattern. Int J Surg Pathol. 2003;11(4):295–302.

    Article  PubMed  Google Scholar 

  11. Liapis G, Boletis J, Skalioti C, et al. Histological spectrum of mycophenolate mofetil-related colitis: association with apoptosis. Histopathology. 2013;63(5):649–58.

    PubMed  Google Scholar 

  12. Star KV, Ho VT, Wang HH, Odze RD. Histologic features in colon biopsies can discriminate mycophenolate from GVHD-induced colitis. Am J Surg Pathol. 2013;37(9):1319–28.

    Article  PubMed  Google Scholar 

  13. Marty FM, Winston DJ, Rowley SD, et al. CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation. N Engl J Med. 2013;369(13):1227–36.

    Article  CAS  PubMed  Google Scholar 

  14. Loeb KR, Yeung CC, Shulman HM. Pathology of hematopoietic cell transplantation. In: Forman SJ, Negrin RS, Antin JH, Appelbaum FR, editors. Thomas’ hematopoietic cell transplantation, vol. 1. 5th ed. Chichester: John Wiley & Sons, Ltd.; 2016. p. 292–328.

    Chapter  Google Scholar 

  15. Otegbeye F, Gale RP, Lazarus HM. Autologous GVHD? Bone Marrow Transplant. 2014;49(11):1349–51.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Howard M. Shulman .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Yeung, C.C.S., Woolston, D.W., Shulman, H.M. (2019). Early Changes of Gut GVHD: Differential Diagnosis and Criteria for Crypt Cell Apoptosis. In: Yeung, C., Shulman, H. (eds) Pathology of Graft vs. Host Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-42099-8_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-42099-8_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-42098-1

  • Online ISBN: 978-3-319-42099-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics